About us

What is Vasthera?

A start-up pharmaceutical company that develops the first-in-class synthetic therapeutics targeting the vascular hyperplasia.

  • Developing the drug candidates for pulmonary arterial hypertension treatment
  • Expanding application of drug candidates to other arterial disease, i.e. restenosis
  • Providing a platform technology for the peroxide-based redox signaling network

Patent Status

  • Pharmaceutical composition for preventing or treating restenosis comprising epidithiodioxopiperazine compound or its derivative; or pharmaceutically acceptable salt thereof, US 9,765,090
  • Epidithiodioxopiperazine compound or its derivatives, and the use thereof, KOREA 10-1633975
  • Epidithiodioxopiperazine compound or its derivatives, and the use thereof, CHINA ZL 201480019817.1